Static Chart IRIDEX Corporation

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-19 EDT			5-day change	1st Jan Change
0.7700 ^USD	-5.48%		-17.12%	-32.46%

10-12	Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use	MT
10-12	Iridex Corporation Announces Publication of Two-Year Clinical Study Demonstrating Favorable Outcomes with Micropulse TLT in Patients with Early, Moderate, and Advanced Primary Glaucoma	CI

Duration

Period